Nick Giannoukakis Selected Research

Nick Giannoukakis Research Topics

Disease

26	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2002
6	Type 2 Diabetes Mellitus (MODY) 12/2022 - 01/2002
6	Insulin Resistance 12/2022 - 01/2002
5	Hyperglycemia 12/2022 - 06/2008
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 06/2008
4	Inflammation (Inflammations) 01/2023 - 11/2009
4	Diabetes Mellitus 05/2015 - 01/2002
4	Diabetes Complications 07/2014 - 05/2002
4	Obesity 11/2011 - 01/2002
3	Neoplasms (Cancer) 03/2013 - 11/2010
2	Non-alcoholic Fatty Liver Disease 01/2023 - 12/2022
2	Diabetic Neuropathies (Diabetic Neuropathy) 07/2014 - 10/2003
1	COVID-19 12/2022
1	Alcoholic Fatty Liver 12/2022
1	Infections 12/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Colitis 01/2018
1	Hypoglycemia (Reactive Hypoglycemia) 11/2011
1	Cataract (Cataracts) 10/2006
1	Prediabetic State (Prediabetes) 10/2005
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2005
1	Arthritis (Polyarthritis) 10/2002
1	Exocrine Pancreatic Insufficiency 05/2002

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 01/2023 - 01/2002
4	Aldehyde Reductase (Aldose Reductase)IBA 07/2014 - 10/2003
3	VaccinesIBA 09/2015 - 06/2008
3	ranirestatIBA 07/2014 - 10/2006
3	Glucose (Dextrose)FDA LinkGeneric 11/2011 - 01/2002
3	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2007 - 04/2003
2	AutoantigensIBA 01/2021 - 05/2012
2	Antisense OligonucleotidesIBA 09/2015 - 06/2008
2	AntigensIBA 09/2015 - 01/2002
2	AcidsIBA 10/2005 - 04/2003
1	CollagenIBA 12/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2022
1	Galectin 3 (LGALS3)IBA 12/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	HydrogelsIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2018
1	Immunoglobulin G (IgG)IBA 03/2013
1	AntibodiesIBA 03/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2013
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	Transcription Factors (Transcription Factor)IBA 05/2012
1	Nucleic AcidsIBA 01/2012
1	OligonucleotidesIBA 01/2012
1	Blood Glucose (Blood Sugar)IBA 11/2011
1	Immunomodulating AgentsIBA 01/2011
1	CytokinesIBA 11/2009
1	BIM 51077IBA 10/2007
1	fosfestrol (Kyorin)FDA Link 10/2006
1	Chaperonin 60IBA 10/2005
1	Peptides (Polypeptides)IBA 10/2005
1	PyridoxamineIBA 04/2005
1	Advanced Glycation End ProductsIBA 04/2005
1	pyridoxamine dihydrochlorideIBA 04/2005
1	fidarestatIBA 10/2003
1	CJC 1131IBA 10/2003
1	Islet Amyloid PolypeptideIBA 04/2003
1	VenomsIBA 04/2003
1	Exenatide (Byetta)FDA Link 04/2003
1	Glucosamine (Dona)IBA 10/2002
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2002
1	Isoantigens (Alloantigen)IBA 01/2002

Therapy/Procedure

14	Therapeutics 01/2019 - 01/2002
3	Transplantation 01/2016 - 01/2002
2	Glycemic Control 01/2023 - 01/2021
2	Islets of Langerhans Transplantation 01/2021 - 04/2006
2	Microspheres (Microsphere) 09/2015 - 06/2008
2	Injections 03/2013 - 04/2003
2	Immunotherapy 01/2011 - 07/2007
2	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2002 - 01/2002
1	Cell Transplantation 04/2006